Company Filing History:
4 out of 156 
1 out of 145 
1 out of 40 Years Active: 2002-2010
Title: Nabil El-Tayar: Innovator in PEGylation Technology
Introduction
Nabil El-Tayar is a prominent inventor based in Milton, MA (US), known for his significant contributions to the field of biotechnology. He holds a total of 6 patents, showcasing his innovative approach to medical treatments and pharmaceutical compositions.
Latest Patents
El-Tayar's latest patents include a method for producing polyol-IFN-β conjugates, specifically PEG-IFN-β conjugates. This process involves the site-specific PEGylation of human IFN-β using a thiol-reactive PEGylating agent. His inventions provide pharmaceutical compositions and methods for treating infections, tumors, and autoimmune and inflammatory diseases. Additionally, he has developed a method for the stepwise attachment of PEG moieties in series to a polypeptide, particularly focusing on IFN-β.
Career Highlights
Throughout his career, Nabil El-Tayar has worked with notable companies such as Applied Research Systems and Merck Serono S.A. His work has significantly impacted the development of therapeutic solutions in the medical field.
Collaborations
El-Tayar has collaborated with esteemed colleagues, including Michael James Roberts and Milton Harris, contributing to advancements in his research and innovations.
Conclusion
Nabil El-Tayar's work in PEGylation technology and his numerous patents highlight his role as a key innovator in biotechnology. His contributions continue to influence the development of effective treatments for various medical conditions.